ALYREF and cholangiocarcinoma: Based on consistent clustering map of 13 m5C RMPs, upregulation of NSUN2, NSUN3, NSUN6, and TET2, coupled with the downregulation of NSUN5 and ALYREF, is associated with poor survival outcomes of CC patients.